Cargando…
2147. Design of a Ligand-Targeted Immunotherapy for Treatment of Influenza Virus Infections
BACKGROUND: Nearly 10% of world’s population is affected by influenza virus infections and more than 26 million Americans were infected during the 2022-2023 flu season, with 290,000-640,000 patients requiring hospitalization. While flu vaccines are widely available, they were only 36% effective duri...
Autores principales: | Shahriar, Imrul, Campbell, Charity L, Kanduluru, Ananda K, Srinivasarao, Madduri, Low, Philip S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678547/ http://dx.doi.org/10.1093/ofid/ofad500.1770 |
Ejemplares similares
-
A universal dual mechanism immunotherapy for the treatment of influenza virus infections
por: Liu, Xin, et al.
Publicado: (2020) -
2147. Sample Size Estimates for Cluster Randomized Trials in Infection Control and Antimicrobial Stewardship
por: Blanco, Natalia, et al.
Publicado: (2018) -
2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
por: Syed, Sadia, et al.
Publicado: (2019) -
Design of a Near Infrared Fluorescent Ureter Imaging Agent for Prevention of Ureter Damage during Abdominal Surgeries
por: Mahalingam, Sakkarapalayam M., et al.
Publicado: (2021) -
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands
por: Hu, Yingwen, et al.
Publicado: (2022)